RIVA, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.093
EU - Europa 5.805
AS - Asia 4.889
SA - Sud America 614
AF - Africa 112
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 4
Totale 23.533
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.918
GB - Regno Unito 1.839
SG - Singapore 1.377
CN - Cina 1.310
IT - Italia 1.135
HK - Hong Kong 757
SE - Svezia 629
VN - Vietnam 565
BR - Brasile 455
DE - Germania 431
FI - Finlandia 345
NL - Olanda 318
RU - Federazione Russa 271
FR - Francia 235
UA - Ucraina 232
TR - Turchia 196
IN - India 133
KR - Corea 103
BG - Bulgaria 94
CA - Canada 89
ID - Indonesia 71
BD - Bangladesh 61
AR - Argentina 50
MX - Messico 50
IQ - Iraq 45
BE - Belgio 40
JP - Giappone 38
CZ - Repubblica Ceca 31
PL - Polonia 30
ZA - Sudafrica 30
ES - Italia 28
IE - Irlanda 24
UZ - Uzbekistan 24
AE - Emirati Arabi Uniti 23
IR - Iran 23
PK - Pakistan 23
AT - Austria 22
CL - Cile 20
CO - Colombia 20
EC - Ecuador 20
LT - Lituania 20
MA - Marocco 20
VE - Venezuela 16
BZ - Belize 15
KE - Kenya 15
MY - Malesia 15
AZ - Azerbaigian 14
PH - Filippine 14
EG - Egitto 13
PY - Paraguay 13
EU - Europa 11
TN - Tunisia 11
RO - Romania 10
CY - Cipro 9
DK - Danimarca 9
SA - Arabia Saudita 9
SK - Slovacchia (Repubblica Slovacca) 9
TW - Taiwan 9
CH - Svizzera 8
NP - Nepal 8
RS - Serbia 8
DZ - Algeria 7
IL - Israele 7
JO - Giordania 7
PE - Perù 7
PS - Palestinian Territory 7
AL - Albania 6
BO - Bolivia 6
GR - Grecia 6
JM - Giamaica 6
OM - Oman 6
TH - Thailandia 6
UY - Uruguay 6
BY - Bielorussia 5
KG - Kirghizistan 5
EE - Estonia 4
ET - Etiopia 4
AM - Armenia 3
AU - Australia 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
KZ - Kazakistan 3
LB - Libano 3
PA - Panama 3
SI - Slovenia 3
SY - Repubblica araba siriana 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CG - Congo 2
CR - Costa Rica 2
KH - Cambogia 2
LU - Lussemburgo 2
MD - Moldavia 2
NI - Nicaragua 2
PT - Portogallo 2
QA - Qatar 2
SN - Senegal 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
AO - Angola 1
Totale 23.509
Salva come PNG Salva come JPEG
Città #
Southend 1.357
Fairfield 1.240
Ashburn 1.234
Santa Clara 1.022
Singapore 877
Woodbridge 804
Hong Kong 746
Chandler 636
Houston 584
Ann Arbor 507
Seattle 478
Jacksonville 428
San Jose 424
Wilmington 424
Dearborn 423
Cambridge 389
Nyköping 350
Hefei 331
Beijing 291
Amsterdam 248
Helsinki 241
London 230
Modena 204
New York 193
Ho Chi Minh City 184
Los Angeles 170
Chicago 162
Hanoi 126
The Dalles 120
Council Bluffs 118
Izmir 105
San Diego 103
Seoul 99
Munich 93
Milan 92
Sofia 90
Princeton 87
Eugene 82
Buffalo 75
Fremont 75
Moscow 73
Lauterbourg 71
Bremen 55
Rome 54
Shanghai 52
Jakarta 46
Orem 46
Dallas 44
Des Moines 40
São Paulo 40
Salt Lake City 39
Boardman 37
Bologna 36
Frankfurt am Main 36
Columbus 34
Brussels 33
Tokyo 32
Redwood City 31
Da Nang 29
Ottawa 28
Boston 25
Atlanta 24
Turku 24
Chennai 23
Toronto 23
Haiphong 22
Tashkent 22
Warsaw 22
Montreal 21
Paris 21
Dublin 19
Elk Grove Village 19
Las Vegas 19
San Francisco 19
Washington 19
Tampa 18
Philadelphia 17
Brooklyn 16
Denver 16
Guangzhou 16
Johannesburg 16
Mexico City 16
Rio de Janeiro 16
Stockholm 16
Belize City 15
Naples 15
Kunming 14
Nairobi 14
Albuquerque 13
Baghdad 13
Manchester 13
Nanjing 13
Phoenix 13
Reggio Emilia 13
Vienna 13
Chiswick 12
Detroit 12
Deventer 12
Dong Ket 12
Lancaster 12
Totale 16.976
Salva come PNG Salva come JPEG
Nome #
Changes in T-Cell Responses Against Human Herpesvirus-8 Correlate with the Disease Course of Iatrogenic Kaposi's Sarcoma in a Patient with Undifferentiated Arthritis 441
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 418
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 399
B cells and herpesviruses: a model of lymphoproliferation 397
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 391
An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells? 367
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 360
Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling 353
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 352
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term Imatinib mesylate treatment. 349
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 347
Assessment of aspergillus-specific T cells for diagnosis of invasive aspergillosis in a leukemic child with liver lesions mimicking hepatosplenic candidiasis 343
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 342
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 342
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 341
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 341
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 340
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 338
From gating to computational flow cytometry: Exploiting artificial intelligence for MRD diagnostics 336
Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma 334
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 332
Mucorales-specific T cells in patients with hematologic malignancies 326
Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients 326
A t(11;20)(p15;q11) may identify a subset of nontherapy-related acute myelocytic leukemia 320
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 318
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 313
Isolated extramedullary relapse after autologous bone marrow transplantation for acute myeloid leukemia: Case report and review of the literature 308
Organising pneumonia mimicking invasive fungal disease in patients with leukaemia. 307
Parvoviruses in blood donors and transplant patients, Italy 304
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 304
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 302
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 301
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 296
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 296
Herpes simplex virus pneumonia during standard induction chemotherapy for acute leukemia: case report and review of literature. 292
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 292
Human Herpesvirus 8 (HHV8) Infection and Related Diseases in Italian Transplant Cohorts. 290
Severe pancytopenia and hemophagocytosis after HHV-8 primary infection in a renal transplant patient successfully treated with foscarnet 288
Epstein-Barr virusassociated pneumonia in an adult patient with severe aplastic anaemia: resolutionafter the transient withdrawal of cyclosporine. 285
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 281
HHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role? 277
Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir 274
Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. 273
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 271
Multicenter Prospective Study for Laboratory Diagnosis of HHV8 Infection in Solid Organ Donors and Transplant Recipients and Evaluation of the Clinical Impact After Transplantation 268
Myocardial ischemia in a patient with acute lymphoblastic leukemia during L-asparaginase therapy 264
Identification and characterization of Aspergillus-specific immune responses to diagnose invasive aspergillosis in high risk patients: a multicenter study 263
Successful Treatment of KSHV Inflammatory Cytokine Syndrome (KICS) after Kidney-Liver Transplant: Correlations with HHV8 miRNome and Specific T-Cell Response 262
Indirect Antitumor Effects of Mammalian Target of Rapamycin Inhibitors Against Kaposi Sarcoma in Transplant Patients 261
Prevalence of Human Herpesvirus-6 Chromosomal Integration (CIHHV-6) in Italian Solid Organ and Allogeneic Stem Cell Transplant Patients 260
Mucorles-specific T cells emerge in the course of invasive mucormucosis and may be used as a surrogate diagnostic marker in high-risk patients 260
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 259
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 258
Cardiac involvement in malignancies. Case 2. Right ventricular lesion as presenting feature of acute promyelocytic leukemia 249
How I treat HHV8/KSHV-related diseases in posttransplant patients. 248
siRNA-BASED THERAPEUTICS: DELIVERY AND TARGETING TO PEL TUMOR BY USING CATIONIC LIPOSOMES 248
Thrombotic complications associated with thalidomide in multiple myeloma: an old problem with new questions and quandaries in decision-making 245
Tumor-targeted immunoliposomal nanosystems to deliver either Cidofovir or Antineoplastic SiRNA against Primary Effusion Lymphoma (PEL) 242
Nanosistemi lipidici targettizzati per il direzionamento di siRNA con attività antineoplastica al linfoma primitivo delle cavità sierose (PEL) 239
Human herpesvirus 8-associated diseases in solid-organ transplantation: importance of viral transmission from the donor 237
LIPOPLEXES PER LA VEICOLAZIONE ED IL DIREZIONAMENTO DI siRNA AL PEL: VALUTAZIONE DELL’EFFICIENZA DI TRATTAMENTO CON SISTEMI LIPIDICI STABILIZZATI 231
Late occurrence of hepatic veno-occlusive disease following gemtuzumab ozogamicin: successful treatment with defibrotide 230
Interferon-alpha may restore sensitivity to tyrosine-kinase inhibitors in Philadelphia chromosome positive acute lymphoblastic leukaemia with F317L mutation 221
Immunoliposomal systems targeting the primary effusion lymphoma (PEL): in vitro study 219
Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia 214
Pneumonia in acute leukaemia:blossoming culprits 211
Cytomegalovirus and ClostridiumDifficile co-infection in severe ulcero-hemorrhagic colitis during inductionchemotherapy for acute lymphoblastic leukemia 209
Is it now the time to update treatment protocols for lymphomas with new anti-virus systems? 209
Differences in Kaposi sarcoma-associated herpesvirus-specific and herpesvirus-non-specific immune responses in classic Kaposi sarcoma cases and matched controls in Sicily. 204
Suppressive effect of human herpesvirus-8/Kaposi sarcoma-associated herpesvirus on in vitro colony formation of hematopoietic progenitor cells 199
May the correlation between Kit-D816 mutation and AML1-ETO level change the use of prognostic factors in t(8;21) AML? 199
Trends in immune cell function assay and donor-specific HLA antibodies in kidney transplantation: A 3-year prospective study 195
KNOCK-DOWN DI BLIMP1/PRDM1 IN CELLULE PEL MEDIANTE siRNA; OTTIMIZZAZIONE DEL SISTEMA DI TRANSFEZIONE E STUDI IN VITRO 191
Formulazione di siRNA anti blimp-1/PRDM in liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di LINFOMA EFFUSIVO PRIMARIO (pel) 191
Efficacy of imatinib mesylate as maintenance therapy in adults with acute lymphoblastic leukemia in first complete remission 188
Formulation and characterization of new Polymeric/Lipidic Hybrid systems for cidofovir delivery 184
β-HHVs and HHV-8 in Lymphoproliferative Disorders. 183
Immunoliposome for the delivery of drugs and SiRNA for the treatment of cancer 179
Successful generation of p190-BCR ABL-specific T-cell lines for prophylaxis/treatment of minimal residual disease in HSCT recipients with Ph+ acute lymphoblastic leukaemia 177
Immunoliposomes to target the Primary Effusion Lymphoma (PEL): in vitro study 174
Linking COVID-19, monocyte activation and sepsis: MDW, a novel biomarker from cytometry 173
Development and characterization of immunoliposomes for Cidofovir and SiRNA delivery: a new strategy for the treatment of Primary Effusion Lymphoma 171
Preclinical Validation of an Advanced Therapy Medicinal Product Based on Cytotoxic T Lymphocytes Specific for Mutated Nucleophosmin (NPM1mut) for the Treatment of NPM1mut-Acute Myeloid Leukemia 144
Feasibility of autologous peripheral blood stem cell mobilization and harvest in adult patients with FLT3-mutated acute myeloid leukemia receiving chemotherapy combined with midostaurin: a single-center experience 141
Immunological and inflammatory features of Kaposi's sarcoma and other Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8-associated neoplasias. 139
Immunoliposomes for the delivery of SiRNA and chemioterapeutic agent to primary effusion lymphoma 138
Identification and validation of diagnostic cut-offs of the ELISpot assay for the diagnosis of invasive aspergillosis in high-risk patients 136
Immunoliposomes for the delivery of SiRNA and chemioterapeutic agent to primary effusion lymphoma 128
The dynamic functions of IRF4 in B cell malignancies 99
Totale 23.747
Salva come PNG Salva come JPEG
Categoria #
all - tutte 83.618
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.618
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021275 0 0 0 0 0 0 0 0 0 0 141 134
2021/20221.747 67 228 221 98 29 63 104 92 175 135 338 197
2022/20231.999 281 248 142 187 281 244 48 184 174 18 105 87
2023/20241.295 41 69 98 96 271 146 137 207 23 24 60 123
2024/20253.847 155 49 76 279 701 541 309 231 431 151 385 539
2025/20266.393 611 367 609 647 969 498 882 332 726 620 132 0
Totale 23.747